Ubs Group Ag Protagenic Therapeutics, Inc.New Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 08, 2023	BUY	$0.35 - $0.61 $3,736 - $6,512	10,676 Added 164.83%	17,153 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.57 - $0.8 $3,110 - $4,365	5,457 Added 535.0%	6,477 $4,000
Q2 2022 Aug 10, 2022	SELL	$0.65 - $0.92 $892 - $1,263	-1,373 Reduced 57.38%	1,020 $1,000
Q1 2022 May 16, 2022	SELL	$0.8 - $1.45 $2,505 - $4,541	-3,132 Reduced 56.69%	2,393 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $2.32 $386 - $663	286 Added 5.46%	5,525 $8,000

Q3 2021 Nov 15, 2021	BUY	$1.75 - $2.77 $3,897 - $6,168	2,227 Added 73.94%	5,239 $10,000
Q2 2021 Aug 13, 2021	BUY	$1.88 - $3.47 $5,662 - $10,451	3,012 New	3,012 $9,000

Others Institutions Holding PTIX

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Protagenic Therapeutics, Inc.new

Ticker PTIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,209,600
Market Cap $14.6M

More about PTIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.